tradmap

ANIX Earnings Anixa Biosciences Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$0 $0 $0 $0 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $556250 $1M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$14M -$7M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$0 -$0 $0 $0 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $1 $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
-$3M -$2M $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–27 of 27
Q3 20262026-07-31-0.232026-09-0910-Q
Q2 20262026-04-30-0.152026-06-1010-Q
Q1 20262026-01-31-0.082026-03-0910-Q
FY 20252025-10-31-0.342026-01-1210-K
Q3 20262025-07-31-0.252026-09-0910-Q
Q2 20262025-04-30-0.192026-06-1010-Q
Q1 20262025-01-31-0.102026-03-0910-Q
FY 20252024-10-31-0.392026-01-1210-K
Q3 20252024-07-31-0.302025-09-1010-Q
Q2 20252024-04-30-0.202025-05-2810-Q
Q1 20252024-01-31-0.102025-03-1110-Q
FY 20242023-10-31-0.322025-01-1010-K
Q3 20242023-07-31-0.232024-09-0610-Q
Q2 20242023-04-30-0.152024-06-0410-Q
Q1 20242023-01-310.082024-03-1210-Q
FY 20232022-10-310.452024-01-1610-K
Q3 20232022-07-31-0.332023-09-0610-Q
Q2 20182018-04-30-0.082018-06-1110-Q
Q2 20182017-04-300.022018-06-1110-Q
Q2 20172016-04-30-0.152017-05-2610-Q
Q1 20162016-01-31-0.182016-02-1910-Q
Q3 20152015-07-31-0.182015-08-1810-Q
Q2 20162015-04-300.162016-05-2010-Q
Q1 20162015-01-310.412016-02-1910-Q
Q3 20152014-07-310.042015-08-1810-Q
Q2 20152014-04-30-0.032015-05-2210-Q
Q1 20152014-01-31-0.022015-03-0910-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.